This large complex of modern offices and science labs was once home to a leading US conglomerate company. Much like any important and top notch company, their headquarters and two different facilities ...
Revenue surged 19% to $4.21 billion, above forecasts, boosted by a 25% sales jump of its cardiovascular products to $2.73 billion. The MedSurg division, which includes endoscopy, urology, and ...
Boston Scientific increased its annual profit forecast on Wednesday, fueled by strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing unexpected events.
Boston Scientific boosted its projection for 2024 sales growth, and is now targeting growth of 16.5%, compared with a previous estimate range between 13.5% and 14.5% from 2023 levels of $14.24 billion ...